Imai, K.; Takai, K.; Hanai, T.; Ideta, T.; Miyazaki, T.; Kochi, T.; Suetsugu, A.; Shiraki, M.; Shimizu, M.
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib. Int. J. Mol. Sci. 2015, 16, 9612-9624.
https://doi.org/10.3390/ijms16059612
AMA Style
Imai K, Takai K, Hanai T, Ideta T, Miyazaki T, Kochi T, Suetsugu A, Shiraki M, Shimizu M.
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib. International Journal of Molecular Sciences. 2015; 16(5):9612-9624.
https://doi.org/10.3390/ijms16059612
Chicago/Turabian Style
Imai, Kenji, Koji Takai, Tatsunori Hanai, Takayasu Ideta, Tsuneyuki Miyazaki, Takahiro Kochi, Atsushi Suetsugu, Makoto Shiraki, and Masahito Shimizu.
2015. "Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib" International Journal of Molecular Sciences 16, no. 5: 9612-9624.
https://doi.org/10.3390/ijms16059612
APA Style
Imai, K., Takai, K., Hanai, T., Ideta, T., Miyazaki, T., Kochi, T., Suetsugu, A., Shiraki, M., & Shimizu, M.
(2015). Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib. International Journal of Molecular Sciences, 16(5), 9612-9624.
https://doi.org/10.3390/ijms16059612